[Assessment of hemoptysis etiology among patients hospitalized in Pneumonology Departament of Medical University of Gdańsk in the years 1998-2002].

Is atmospheric pressure change an Independent risk factor for hemoptysis? Pak J Med Sci (2014) 0.75

[Reccomendation of Polish Respiratory Society for palliative care in chronic lung diseases]. Pneumonol Alergol Pol (2012) 1.48

[The effects of pulmonary rehabilitation on the quality of life in patients with COPD]. Pneumonol Alergol Pol (2007) 1.38

[Sarcoidosis--clinical features, diagnosis and treatment]. Przegl Lek (2004) 0.85

[Quality of life of patients with asthma which has been well and poorly controlled]. Pneumonol Alergol Pol (2007) 0.84

[Invasive aspergillosis of the paranasal sinuses, lung and brain]. Pneumonol Alergol Pol (2008) 0.82

A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life. Lung Cancer (2002) 0.81

[Style of coping with stress and emotional functioning in patients with asthma]. Pneumonol Alergol Pol (2009) 0.80

Risk factors for anaphylaxis in patients with mastocytosis. Pol Arch Med Wewn (2015) 0.77

Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol (2014) 0.77

Intima-media thickness in patients with obstructive sleep apnea without comorbidities. Lung (2013) 0.75

[Assessment of drug therapy in chronic pulmonary obstructive disease]. Pol Merkur Lekarski (2004) 0.75

[Usefulness of exercise test and peak inspiratory flow (PIF) measurement in diagnosis and management of bronchial asthma]. Pneumonol Alergol Pol (2004) 0.75

[Addison's diseases caused by adrenal tuberculosis--case report]. Pol Merkur Lekarski (2004) 0.75

Automated detection of sleep apnea and hypopnea events based on robust airflow envelope tracking in the presence of breathing artifacts. IEEE J Biomed Health Inform (2014) 0.75

[Pulmonary actinomycosis - a case report]. Pneumonol Alergol Pol (2012) 0.75

[Assessment of exercise test and bronchial reversibility test as tools for asthma diagnosis in patients with normal spirometry]. Przegl Lek (2006) 0.75

[Accuracy of spirometry performed by general practitioners and pulmonologists in Pomeranian Region in the "Prevention of COPD" NHS program]. Pneumonol Alergol Pol (2009) 0.75

[Serum eosinophil cationic protein (ECP) in patients with perennial rhinitis and atopic dermatitis, allergic to house dust mites]. Pol Merkur Lekarski (2005) 0.75

[Isolated sarcoidosis of upper respiratory tract--a description of 2 cases]. Pneumonol Alergol Pol (2008) 0.75

Cellular composition of induced sputum in sarcoidosis. Pneumonol Alergol Pol (2013) 0.75

[Diagnosis and treatment of tobacco dependence]. Pneumonol Alergol Pol (2005) 0.75

[Chemotherapy of advanced non-small cell lung cancer with the combination of gemcitabine and cisplatin]. Pneumonol Alergol Pol (2002) 0.75

Transthoracic lung ultrasonography in pulmonary alveolar proteinosis - case report. Sarcoidosis Vasc Diffuse Lung Dis (2013) 0.75

[Malignant mesothelioma of the pleura--diagnostic difficulties]. Pol Merkur Lekarski (2004) 0.75

Tracheobronchopathia osteochondroplastica—case report and literature review. Pneumonol Alergol Pol (2015) 0.75

[The prevalence of serum IgG antibodies against HTLV viruses type I and II in sarcoidosis patients]. Pneumonol Alergol Pol (2002) 0.75

[The induced sputum--methodology and clinical usefulness]. Pneumonol Alergol Pol (2006) 0.75

[Nasal provocation tests with house dust mite in patients with perennial rhinitis]. Otolaryngol Pol (2003) 0.75